Cargando…
More light on cancer and COVID-19 reciprocal interaction
Cancer patients are vulnerable to COVID-19 with consequences on treatment delays and on mortality rate. This Comment explores the interaction between COVID-19 and cancer with attention paid to the modulation by cancer treatments of both ADAM17 and TMPRSS2, the proteases which control ACE2 processing...
Autores principales: | Brest, Patrick, Mograbi, Baharia, Hofman, Paul, Milano, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039039/ https://www.ncbi.nlm.nih.gov/pubmed/33531686 http://dx.doi.org/10.1038/s41416-020-01246-0 |
Ejemplares similares
-
COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021) -
Host genetic variability and determinants of severe COVID-19
por: Brest, Patrick, et al.
Publicado: (2023) -
Using Genetics To Dissect SARS-CoV-2 Infection
por: Brest, Patrick, et al.
Publicado: (2021) -
Host Polymorphisms May Impact SARS-CoV-2 Infectivity
por: Brest, Patrick, et al.
Publicado: (2020) -
Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
por: Bontoux, Christophe, et al.
Publicado: (2022)